Use and effect of short acting β-agonist trials in children aged 2–59 months presenting with respiratory symptoms in low-, middle-, and high-income, primary care settings.
收藏数据链接：
官方服务：
资源简介：
Use and effect of short acting β-agonist trials in children aged 2–59 months presenting with respiratory symptoms in low-, middle-, and high-income, primary care settings.
创建时间：
2019-11-06
